Pavel V Pogodin
Overview
Explore the profile of Pavel V Pogodin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schimunek J, Seidl P, Elez K, Hempel T, Le T, Noe F, et al.
Mol Inform
. 2023 Oct;
43(1):e202300262.
PMID: 37833243
The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient...
2.
Pogodin P, Kiseleva O, Ilgisonis E
Curr Issues Mol Biol
. 2023 May;
45(4):3406-3418.
PMID: 37185747
Database records contain useful information, which is readily available, but, unfortunately, limited compared to the source (publications). Our study reviewed the text fragments supporting the association between the biological macromolecules...
3.
Lagunin A, Rudik A, Pogodin P, Savosina P, Tarasova O, Dmitriev A, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675202
In vitro cell-line cytotoxicity is widely used in the experimental studies of potential antineoplastic agents and evaluation of safety in drug discovery. In silico estimation of cytotoxicity against hundreds of...
4.
Ilgisonis E, Pogodin P, Kiseleva O, Tarbeeva S, Ponomarenko E
J Pers Med
. 2022 Mar;
12(3).
PMID: 35330478
Within the Human Proteome Project initiative framework for creating functional annotations of uPE1 proteins, the neXt-CP50 Challenge was launched in 2018. In analogy with the missing-protein challenge, each command deciphers...
5.
Dmitriev A, Rudik A, Karasev D, Pogodin P, Lagunin A, Filimonov D, et al.
Pharmaceutics
. 2021 Apr;
13(4).
PMID: 33924315
Drug-drug interactions (DDIs) can cause drug toxicities, reduced pharmacological effects, and adverse drug reactions. Studies aiming to determine the possible DDIs for an investigational drug are part of the drug...
6.
Lagunin A, Ivanov S, Gloriozova T, Pogodin P, Filimonov D, Kumar S, et al.
Sci Rep
. 2020 Jan;
10(1):257.
PMID: 31937840
Dementia is a major cause of disability and dependency among older people. If the lives of people with dementia are to be improved, research and its translation into druggable target...
7.
Pogodin P, Lagunin A, Rudik A, Druzhilovskiy D, Filimonov D, Poroikov V
J Chem Inf Model
. 2019 Oct;
59(11):4513-4518.
PMID: 31661960
Discovery of new antibacterial agents is a never-ending task of medicinal chemistry. Every new drug brings significant improvement to patients with bacterial infections, but prolonged usage of antibacterials leads to...
8.
Lagunin A, Geronikaki A, Eleftheriou P, Pogodin P, Zakharov A
J Chem Inf Model
. 2019 Jan;
59(2):713-730.
PMID: 30688458
Numerous studies have been published in recent years with acceptable quantitative structure-activity relationship (QSAR) modeling based on heterogeneous data. In many cases, the training sets for QSAR modeling were constructed...
9.
Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes
Dmitriev A, Lagunin A, Karasev D, Rudik A, Pogodin P, Filimonov D, et al.
Curr Top Med Chem
. 2019 Jan;
19(5):319-336.
PMID: 30674264
Drug-drug interaction (DDI) is the phenomenon of alteration of the pharmacological activity of a drug(s) when another drug(s) is co-administered in cases of so-called polypharmacy. There are three types of...
10.
Lagunin A, Romanova M, Zadorozhny A, Kurilenko N, Shilov B, Pogodin P, et al.
Front Pharmacol
. 2018 Oct;
9:1136.
PMID: 30364128
Estimation of interaction of drug-like compounds with antitargets is important for the assessment of possible toxic effects during drug development. Publicly available online databases provide data on the experimental results...